CS logo
small CS logo
CEMIC (Centro de Educación Médica e Investigaciones Clínicas)

Buenos Aires, Argentina
Educational institution in Buenos Aires
Valdenegro 4337, C1430EFA CABA

About CEMIC (Centro de Educación Médica e Investigaciones Clínicas)


"El IUC tiene como misión desarrollar la docencia universitaria, la investigación y la extensión para: • la formación integral de profesores y alumnos, promoviendo valores y actitudes vitales que hacen a la tradición humanística de la cultura universal; • en un ambiente válido que estimule la búsqueda de enfoques integradores partiendo de la diversidad y del pluralismo; • buscando el equilibrio entre las tradiciones y las innovaciones y entre el desarrollo armónico de la mente y el cuerpo; y • estimulando a los estudiantes a lograr una permanente actualización y perfeccionamiento a través de su propio interés y esfuerzo."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Bio Products Laboratory
1
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
1
Fundacion GESICA
1
National Institute of Allergy and Infectious Diseases (NIAID)
1
Unity Health Toronto
1
Total Rows: 6

Clinical Trials at CEMIC (Centro de Educación Médica e Investigaciones Clínicas)


During the past decade, CEMIC (Centro de Educación Médica e Investigaciones Clínicas) conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100111111111100110000000000Started TrialsCompleted Trails201620172018201920202021202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
2007-09-01
2011-08-01
Completed
35
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
2009-03-01
2011-10-01
Completed
30
Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
2010-09-01
2017-03-30
Completed
881
Asynchrony During Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome
2016-05-25
2019-02-01
Completed
103
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
2018-11-20
2021-11-15
Completed
214
Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
2020-11-23
2024-11-01
Recruiting
740
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
2019-09-26
2029-09-29
Active, not recruiting
1,064
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
2021-11-17
2026-12-29
Recruiting
690

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Bio Products Laboratory" with 1 trials sponsored, "Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno" with 1 trials sponsored, "Fundacion GESICA" with 1 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" #1 collaborator was "Applied Health Research Centre" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "University of Toronto" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJanssen Research &Development, LLC: 4Janssen Research &Development, LLC: 4Bio Products Laboratory: 1Bio Products Laboratory: 1Centro de EducaciónMedica eInvestigaciones ClínicasNorberto Quirno: 1Centro de EducaciónMedica eInvestigaciones ClínicasNorberto Quirno: 1Fundacion GESICA: 1Fundacion GESICA: 1National Institute ofAllergy and InfectiousDiseases (NIAID): 1National Institute ofAllergy and InfectiousDiseases (NIAID): 1Unity Health Toronto: 1Unity Health Toronto: 1

Created with Highcharts 11.1.0Top CollaboratorsApplied HealthResearch Centre: 1Applied HealthResearch Centre: 1Canadian Institutes ofHealth Research (CIHR):1Canadian Institutes ofHealth Research (CIHR):1University of Toronto: 1University of Toronto: 1

Clinical Trials Conditions at CEMIC (Centro de Educación Médica e Investigaciones Clínicas)


According to Clinical.Site data, the most researched conditions in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" are "ARDS" (1 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chronic Idiopathic Thrombocytopenic Purpura" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" in a lesser frequency.

Clinical Trials Intervention Types at CEMIC (Centro de Educación Médica e Investigaciones Clínicas)


Most popular intervention types in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lazertinib" (2 trials), "Placebo" (2 trials), "Amantadine, Ribavirin, Oseltamivir" (1 trials), "Amivantamab" (1 trials) and "Amivantamab Intravenous" (1 trials). Other intervention names were less common.

Clinical Trials Genders at CEMIC (Centro de Educación Médica e Investigaciones Clínicas)


The vast majority of trials in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)" are 9 trials for "All" genders.

Clinical Trials Status at CEMIC (Centro de Educación Médica e Investigaciones Clínicas)


Currently, there are NaN active trials in "CEMIC (Centro de Educación Médica e Investigaciones Clínicas)". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CEMIC (Centro de Educación Médica e Investigaciones Clínicas), undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CEMIC (Centro de Educación Médica e Investigaciones Clínicas), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 3Phase 2: 3Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Recruiting: 3Recruiting: 3Active, not recruiting: 1Active, not recruiting: 1